Monographie - Docetaxel

Ostatnia aktualizacja :
03/05/2024

Docetaxel

Struktura chemiczna

Nazwa handlowa

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Adenex	KolumbiaKolumbia
Asodocel	Argentyna
Axogen	Chile
Bagotaxel	Chile
Bendadocel	Niemcy
Brecasta	Chile
Celtere	Peru
Daxotel	Chile, Egipt, KolumbiaKolumbia, Malezja
Doce NC	Niemcy
Docefrez	Indie, Stany Zjednoczone Ameryki
Docekebir	Argentyna
Docetax	Iran, Wenezuela
Docetaxin	Niemcy
Docewin	Maroko
Dolectran	Argentyna
Donataxel	Argentyna, Ekwador, Peru
Doxel	Turcja, Wenezuela
Doxetal	Argentyna
Doxitax	Turcja
Oncodocel	KolumbiaKolumbia, Peru
Onkotaxel	Austria, KolumbiaKolumbia
Ribodocel	Niemcy
Santax	Turcja
Tadocel	Turcja
Taxceus	Wielka Brytania
Taxotan	Niemcy
Taxotere	Arabia Saudyjska, Argentyna, Australia, Austria, Belgia, Chile, Chorwacja, Dania, Egipt, Ekwador, Finlandia, Francja , Grecja, Hiszpania, Holandia, Iran, Islandia, Japonia, Kanada, KolumbiaKolumbia, Luksemburg, Malezja, Maroko, Meksyk, Niemcy, Norwegia, Nowa Zelandia, Polska, Portugalia, Rumunia, Stany Zjednoczone Ameryki, Szwajcaria, Szwecja, Tajlandia, Tunisie, Turcja, Węgry, Wenezuela, Wielka Brytania, Włochy, Zjednoczone Emiraty Arabskie
Texot	Argentyna
Tolnexa	Rumunia
Zenotere	Indie, Peru

Bibliografia : Docetaxel

	Typ	Publikacja
140	Czasopismo	Pearson SD, Trissel LA. Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components. Am J Hosp Pharm 1993 ; 50: 1405-1409.
250	Czasopismo	Mazzo DJ, Nguyen-Huu JJ, Pagniez S, Denis P. Compatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materials. Am J Health-Syst Pharm 1997 ; 54: 566-569.
251	Czasopismo	Trissel LA, Gilbert DL, Martinez JF. Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
1423	Czasopismo	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1660	Czasopismo	Thiesen J, Krämer I. Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers. Pharm World Sci 1999 ; 21: 137-141.
1662	Czasopismo	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1754	Czasopismo	Trissel LA, Gilbert DL, Wolkin AC. Compatibility of docetaxel with selected drugs during simulated Y-site administration. Int J Pharm Compound 1999 ; 3: 241-244.
1940	Czasopismo	Xu QA, Trissel LA. Stability of palonosetron hydrochloride with paclitaxel and docetaxel during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 1596-1598.
1953	Czasopismo	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982	Czasopismo	Trissel LA, Ogundele AB. Compatibility of anidulafungin with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 834-837.
2175	Czasopismo	Dalle M, Sautou-Miranda V, Balayssac D, Bourlon S, Bagel S, Chopineau J. Peut-on conditionner les solutions de docétaxel dans des poches en PVC ? J Pharm Clin 2006 ; 25, 3: 147-152.
2210	Czasopismo	Walker S.E, Charbonneau F, Law S. Stability of Docetaxel Solution after Dilution in Ethanol and Storage in Vials and after Dilution in Normal Saline and Storage in Bags. Can J Hosp Pharm 2007 ; 60, 4: 231-237.
2262	Czasopismo	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2341	Plakat	Bourlon S, Sautou-Miranda V, Dalle M. Release of di(2-ethylhexyl)phtalate from polyvinylchloride bags during docetaxel infusions Poster ESCP Stockholm May 2005
3130	Laboratorium	Docétaxel (Taxotere®) – Résumé des caractéristiques du produits Sanofi Avantis France 2009
3163	Czasopismo	Acott SR, Hart M. Physical and chemical stability of Taxotere 1-vial 20mg/mL infusion solution following refrigerated storage. EJHP 2010 ; 16, 5: 26-28.
3195	Czasopismo	MacLeod S, Sewell G. Physical and chemical stability of docetaxel infusions. EJHP 2011 ; 17, 2: 39-43.
3215	Czasopismo	Hart MC, Ahmed W. Taxotere 1-vial (docetaxel 20 mg/ml) physical and chemical stability over 28 days in infusion bags containing 0.9% saline solution and 5% glucose solution. EJOP 2011 ; 5,1: 24-27.
3277	Czasopismo	Yang Z, Cameron S, Paul H. Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration. Int J Pharm Compound 2012 ; 16, 1 : 82-85.
3804	Czasopismo	Lazzarini R, Salvadori S, Trapella C, Guerrini R, Marzola E, Pasini G, Dalpiaz A. Physicochemical stability of cabazitaxel and docetaxel solutions. EJHP 2014 ;22:150-155.
3937	Czasopismo	Park K.H, Chung D.J. Stability study of docetaxel solution (0.9% saline) using Non-PVC and PVC tubes for intravenous administration. Biomat Res 2015 ; 19, 2

Mentions Légales